Vasopressin antagonism for decompensated right-sided heart failure

Targeted treatment for decompensated right heart failure (RHF) with or without left heart failure is lacking. Vasopressin antagonists (vaptans) may offer an option by increasing urine output and fluid mobilization when used in acute decompensated HF without impacting blood pressure or renal function, both common complications of loop diuretics.

Source: International Journal of Cardiology - August 13, 2018 Category: Cardiology Authors: Andrija Vidic, Jerrica E. Shuster, Zackary D. Goff, Anuradha Godishala, Susan M. Joseph, John T. Chibnall, Paul J. Hauptman Tags: Short communication Source Type: research